Maria-Valeria Karakasi

Maria-Valeria Karakasi

Auto-generated profile, based on publicly available information

Maria-Valeria Karakasi

3rd Department of Psychiatry Aristotle University of Thessaloniki – School of Medicine Thessaloniki Greece

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of Forensic and Legal Medicine
Verified
Journal Article
Closed access
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
ENEvangelos Nastoulis
Evangelos Nastoulis
KZKonstantinos Zisopoulos
Konstantinos Zisopoulos
MMMaria Markopoulou
Maria Markopoulou
MAMaria Alexandri
Maria Alexandri
PPPavlos Pavlidis
Pavlos Pavlidis

13 July 2020 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
SPStavroula A. Papadodima
Stavroula A. Papadodima
MKMaria ‐ Valeria Karakasi
Maria ‐ Valeria Karakasi
PPPavlos Pavlidis
Pavlos Pavlidis
ENEvangelos Nastoulis
Evangelos Nastoulis
KFKallirroi Fragkou
Kallirroi Fragkou
CSChara Spiliopoulou
Chara Spiliopoulou

3 March 2023 in Muscle & Nerve
Verified
Journal Article
Open access
Christos BakirtzisChristos Bakirtzis
Christos Bakirtzis
MBMarina‐Kleopatra Boziki
Marina‐Kleopatra Boziki
MKMaria‐Valeria Karakasi
Maria‐Valeria Karakasi
TMTheodoros Moysiadis
Theodoros Moysiadis
NGNikolaos Grigoriadis
Nikolaos Grigoriadis
Introduction/AimsThere is limited knowledge regarding the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines omicron n coronavirus disease 2019 (COVID-19) disease course in people with myasthenia gravis. In this study, we aimed to investigate whether SARS-CoV-2 vaccination influences hospitalization and mortality due to COVID-19 in this population. MethodsThis is a retrospective analysis of administrative data extracted from the Greek nationwide database that holds the COVID-19 disease and vaccination registry, as well as all medical prescription records. The study period extended from the onset of the pandemic (February 2020) until the 10th of January 2022. ResultsWe identified 278 people with myasthenia gravis (mean age 58.1 +/- 17.2, 47.5% males) who tested positive for SARS-CoV-2. Of those, 139 (50%) were not vaccinated at the time of infection. Multivariable binary logistic regression analysis showed that the probability of hospitalization increased with age (odds ratio [OR]: 1.058; 95% confidence interval [CI], 1.036-1.080; p < .001) and immunosuppressive treatment (OR: 2.872; 95% CI 1.412-5.839; p = .004), and decreased with vaccination (OR: 0.244; 95% CI 0.132-0.453; p < .001). The probability of a fatal outcome increased with age (OR: 1.085; 95% CI 1.043-1.129; p < .001) and decreased with vaccination (OR: 0.315; 95% CI 0.125-0.791; p = .014). DiscussionSARS-CoV-2 vaccination significantly reduces hospitalization and mortality due to COVID-19 in people with myasthenia gravis. This study regarding the efficacy of these vaccines, together with previous studies regarding their safety, provide evidence to support their use in people with myasthenia gravis.

1 June 2016 in American Journal of Forensic Medicine & Pathology
Verified
Journal Article
Closed access
PPPavlos Pavlidis
Pavlos Pavlidis
TDTheodora-Eleftheria Deftereou
Theodora-Eleftheria Deftereou
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
NPNikolaos Papadopoulos
Nikolaos Papadopoulos
AZAthanassios Zissimopoulos
Athanassios Zissimopoulos
MLMARIA LAMBROPOULOU
MARIA LAMBROPOULOU
The purpose of this study was to investigate chronic intravenous heroin abuse and its potential to induce acute myocardial infarction (AMI). It also aims to examine the causative factors and the incidence of heroin-induced myocardial infarction. The hearts of 113 intravenous heroin abusers were studied for a duration exceeding 3 years. The parameters studied included sex, age, time of intravenous heroin abuse, medical history, and body and heart weight. Macroscopic histological studies of the heart were also performed. The histological examination revealed only 1 case of AMI. The victim was an intravenous heroin abuser for the last 7 years. The age and the medical history of the victim do not act as dissuading factors for the potential of an AMI. The incidence of heroin-induced myocardial infarction is rare, and the actual mechanism remains unclear. The increased heart weight in relation to the increased thickness of the heart walls may be an aggravating factor, and thus, it is a fact that should be investigated.

1 January 2020 in Korean Journal of Neurotrauma
Verified
Journal Article
Open access
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
ANAlexandrina Nikova
Alexandrina Nikova
CVChristina Valsamidou
Christina Valsamidou
PPPavlos Pavlidis
Pavlos Pavlidis
TBTheodossios A. Birbilis
Theodossios A. Birbilis
Karakasi MV, et al. Korean J Neurotrauma. 2020 Feb;16:e6. https://doi.org/10.13004/kjnt.2020.16.e6

1 January 2019 in Korean Journal of Neurotrauma
Verified
Journal Article
Open access
ANAlexandrina Nikova
Alexandrina Nikova
MKMaria-Valeria Karakasi
Maria-Valeria Karakasi
PPPavlos Pavlidis
Pavlos Pavlidis
TBTheodossios Birbilis
Theodossios Birbilis
IDIvaylo Dimitrov
Ivaylo Dimitrov
Nikova AS, et al. Korean J Neurotrauma. 2019 Jul;15:e34. https://doi.org/10.13004/kjnt.2019.15.e34